Revolution Medicines' potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial....
By CNBC ยท CNBC
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial.